Trial Profile
A Phase 3 Multi-Center, Randomized, Double-Blinded, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy, Tolerability and Safety of Once Daily SB204 and Vehicle Gel in the Treatment of Acne Vulgaris
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Jul 2023
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary)
- Indications Acne vulgaris
- Focus Registrational; Therapeutic Use
- Sponsors Novan Inc
- 10 Nov 2021 According to a Novan Inc. media release, potential submission of an NDA targeted for 2024.
- 13 Feb 2018 According to a Novan media release, data will be presented at the 2018 Annual Meeting of the American Academy of Dermatology (AAD).
- 14 Dec 2017 Status changed from active, no longer recruiting to completed.